Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bayer
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
A prospective, randomized, double dummy, double blind, multi-center trial comparing the safety and efficacy of moxifloxacin 400 mg IV QD 24 hours to that of ertapenem 1.0 g IV QD 24 hours for 5 to 14 days for the treatment of subjects with complicated intra-abdominal infections
Primary objective is to compare the safety and efficacy of intravenous moxifloxacin 400 mg administered once daily with those of intravenous ertapenem 1 g once a day in adult subjects with cIAI that r...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Exploring the efficacy and safety of rivaroxaban to support elective percutaneous coronary intervention
The aim of this study is to assess whether rivaroxaban, as compared to unfractionated heparin, on the background of standard dual antiplatelet therapy (DAPT), can effectively suppress thrombosis, and ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Long-term extension, multi-centre, multi-national study to evaluate the safety and tolerability of oral BAY 63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg tid) in patients with symptomatic Pulmonary Arterial Hypertension (PAH
to evaluate the long-term safety and tolerability of oral BAY 63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg tid) in treatment of naive patients and patients pretreated with an Endothelin Receptor Antagonist...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman
Between 18 years
and 99 years
Bayer
Update Il y a 4 ans
Étude BAY 88-8223 / 17096 : étude de phase 2, randomisée, en double aveugle, comparant l’efficacité et la tolérance d’un traitement associant le dichlorure de radium-223, l'exémestane et l'évérolimus par rapport à un traitement associant un placebo, l'exémestane et l'évérolimus, chez des patientes ayant un cancer du sein métastatique HER2-négatif, RH-positifs, avec métastases osseuses. [essai clos aux inclusions]
BAY 88-8223 / 17096 Essai de phase II randomisé, en double aveugle et contrôlé versus placebo, portant sur le dichlorure de radium-223 en association avec l'exémestane et l'évérolimus comparé au place...
Country
France
organs
Sein
,
Métastases osseuses
Specialty
Radiothérapie
,
Chimiothérapie
,
Hormonothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Bayer Pharmaceuticals Corporation
Update Il y a 4 ans
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery
The objective of this study is to evaluate the safety and efficacy of aprotinin as compared to placebo, in reducing the need for blood transfusion in adult subjects undergoing elective spinal fusion s...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
An uncontrolled open label multicenter phase II safety study of BAY 73-4506 in patients with hepatocellular carcinoma (HCC)
To assess the safety profile of BAY 73-4506 in patients with hepatocellular carcinoma (HCC)
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
A 54 week treatment, randomized, multi center, double blind, placebo controlled study to assess the safety and efficacy of NEBIDO 1000 mg (4 ml) in elderly men with symptomatic late onset hypogonadism (SLOH)
Efficacy and safety of NEBIDO in men with symptomatic late onset hypogonadism (SLOH) as characterized in the protocol inclusion criteria: To assess the change from baseline in lean body mass after ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
A clinical trial to investigate if different doses of BAY 85-3934 are safe and effective in patients with anaemia due to chronic kidney disease, who have not received any previous treatment to help produce red blood cells and are not undergoing dialysis treatment. Ensayo Clinico para investigar la seguridad y efectividad de diferentes dosis de BAY 85-3934, en pacientes con anemia por enfermedad renal crónica, que no han recibido tratamiento previo para ayudar a producir globulos rojos y que no están en tratamiento de dialisis
To evaluate the efficacy for up to 16 weeks of fixed dose treatment with BAY 85-3934 versus placebo as measured by haemoglobin (Hb) levels. Evaluar la eficacia durante 16 semanas del tratamiento...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Phase III Trial Comparing Capecitabine in Combination with Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
The objective of this phase-III trial is to compare the efficacy and safety of sorafenib in combination with capecitabine versus capecitabine in combination with placebo in the treatment of subjects w...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Bayer
Update Il y a 4 ans
Etude CHRONOS-3 : étude de phase 3, randomisée comparant l’efficacité et la tolérance du copanlisib associé au rituximab par rapport à un placebo associé au rituximab, chez des patients ayant un lymphome non-hodgkinien à cellules B indolent et en rechute.
Un lymphome non hodgkinien est un cancer qui se développe à partir de cellules du système lymphatique, les lymphocytes. Il s’agit d’un type de globules blancs impliqués dans les réactions de défense d...
Country
France
organs
Lymphomes non hodgkinien
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Previous
10
11
12
13
14
15
16
17
18
19
Next